Skip to content

MyMD Pharmaceuticals Announces Issuance of US Patent for Synthetic Cannabinoid Compounds …

MyMD Pharmaceuticals Announces Issuance of US Patent for Synthetic Cannabinoid Compounds …

Supera-CBD is being developed to address anxiety, chronic pain, addiction, and seizures, and is on a path toward human clinical trials as a therapy for …
See all stories on this topic

Consumer mHealth Market Rewriting It’s Growth Cycle : NTT Docomo, Garmin

Understanding the segments helps in identifying the importance of different factors … Some of the Major Companies covered in this Research are Apple, … and Volume from 2021 to 2026) : Diagnosis, Monitoring & De-addiction … wise report version like North America, LATAM, Europe or Southeast Asia.
See all stories on this topic

Game Booster Apps Market to Witness Stunning Growth with Razer, Iobit, Soocii

Increasing Addiction of Online Gaming Among Children and Adults; The … North America (United States, Mexico & Canada); South America (Brazil, …
See all stories on this topic

Matter Health Achieves 2X Growth Across Revenue, Staff and Client Portfolio

Matter Health’s recent addition of notable clients to its roster include: … care solution used by premier healthcare organizations across North America. … beat addiction through evidence-based medicine, community and holistic care.
See all stories on this topic

Matter Health Achieves 2X Growth Across Revenue, Staff and Client Portfolio

Matter Health’s recent addition of notable clients to its roster include: … beat addiction through evidence-based medicine, community and holistic care. … Founded in 2003, with offices across North America, Matter works with the …
See all stories on this topic

Published inAddiction

Be First to Comment

Leave a Reply